Takeda Pharmaceutical Co Ltd (NYSE:TAK)

Delayed Data
As of Nov 28
 +0.005 / +0.03%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 12 analysts offering 12-month price forecasts for Takeda Pharmaceutical Co Ltd have a median target of 14.40, with a high estimate of 23.39 and a low estimate of 12.57. The median estimate represents a -1.07% decrease from the last price of 14.56.

Analyst Recommendations

The current consensus among 14 polled investment analysts is to Buy stock in Takeda Pharmaceutical Co Ltd. This rating has held steady since November, when it was upgraded from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 143.34%
Growthannually 21.39%


Growthquarterly -0.28%
Growthannually -4.02%
Key to the earnings and sales forecast charts.